Ken Fisher's PFE Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 51.95 M shares of Pfizer Inc. (PFE) worth $1.29 B, representing 0.44% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in PFE, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 36.29 M shares. Largest reduction occurred in Q1 2020, reducing 39.93 M shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2.66 M | Add 5.41% | 51.95 M | $24.90 |
| Q3 2025 | +897,786 | Add 1.86% | 49.29 M | $25.48 |
| Q2 2025 | +950,239 | Add 2.00% | 48.39 M | $24.24 |
| Q1 2025 | +36.29 M | Add 325.54% | 47.44 M | $25.34 |
| Q4 2024 | +4.94 M | Add 79.52% | 11.15 M | $26.53 |
| Q3 2024 | +4.31 M | Add 226.69% | 6.21 M | $28.94 |
| Q2 2024 | -2,394 | Reduce 0.13% | 1.9 M | $27.98 |
| Q1 2024 | +15,888 | Add 0.84% | 1.9 M | $27.75 |
| Q4 2023 | -46,423 | Reduce 2.40% | 1.89 M | $28.79 |
| Q3 2023 | +9,537 | Add 0.50% | 1.93 M | $33.17 |
| Q2 2023 | +463 | Add 0.02% | 1.92 M | $36.68 |
| Q1 2023 | -31,983 | Reduce 1.64% | 1.92 M | $40.80 |
| Q4 2022 | -99,745 | Reduce 4.85% | 1.96 M | $51.24 |
| Q3 2022 | -404,984 | Reduce 16.46% | 2.06 M | $43.76 |
| Q2 2022 | -12,419 | Reduce 0.50% | 2.46 M | $52.43 |
| Q1 2022 | -34,667 | Reduce 1.38% | 2.47 M | $51.77 |
| Q4 2021 | +63,262 | Add 2.59% | 2.51 M | $59.05 |
| Q3 2021 | -2,276 | Reduce 0.09% | 2.44 M | $43.01 |
| Q2 2021 | -38,794 | Reduce 1.56% | 2.45 M | $39.16 |
| Q1 2021 | -58,521 | Reduce 2.30% | 2.49 M | $36.23 |
| Q4 2020 | +173,845 | Add 7.34% | 2.54 M | $36.81 |
| Q3 2020 | -82,334 | Reduce 3.36% | 2.37 M | $36.70 |
| Q2 2020 | -3 M | Reduce 54.99% | 2.45 M | $32.70 |
| Q1 2020 | -39.93 M | Reduce 87.99% | 5.45 M | $32.64 |
| Q4 2019 | +83,775 | Add 0.18% | 45.38 M | $39.18 |
| Q3 2019 | +1.16 M | Add 2.62% | 45.29 M | $35.93 |
| Q2 2019 | +1.56 M | Add 3.66% | 44.13 M | $43.32 |
| Q1 2019 | +743,137 | Add 1.78% | 42.57 M | $42.47 |
| Q4 2018 | +1.35 M | Add 3.34% | 41.83 M | $43.65 |
| Q3 2018 | +1.03 M | Add 2.62% | 40.48 M | $44.07 |
| Q2 2018 | +1.67 M | Add 4.42% | 39.45 M | $36.28 |
| Q1 2018 | +1.4 M | Add 3.85% | 37.77 M | $35.49 |
| Q4 2017 | +1.25 M | Add 3.56% | 36.37 M | $36.22 |
| Q3 2017 | +1.09 M | Add 3.19% | 35.12 M | $35.70 |
| Q2 2017 | +1.28 M | Add 3.89% | 34.04 M | $33.59 |
| Q1 2017 | +554,777 | Add 1.72% | 32.76 M | $34.21 |
| Q4 2016 | +368,385 | Add 1.16% | 32.2 M | $32.48 |
| Q3 2016 | +111,838 | Add 0.35% | 31.84 M | $33.87 |
| Q2 2016 | -21,618 | Reduce 0.07% | 31.72 M | $36.15 |
| Q1 2016 | -588,269 | Reduce 1.82% | 31.75 M | $32.50 |
| Q4 2015 | +407,538 | Add 1.28% | 32.33 M | $32.28 |
| Q3 2015 | +110,130 | Add 0.35% | 31.93 M | $31.41 |
| Q2 2015 | +608,478 | Add 1.95% | 31.82 M | $33.53 |
| Q1 2015 | +11,856 | Add 0.04% | 31.21 M | $34.79 |
| Q4 2014 | -506,080 | Reduce 1.60% | 31.2 M | $31.15 |
| Q3 2014 | +220,006 | Add 0.70% | 31.7 M | $29.57 |
| Q2 2014 | +1.24 M | Add 4.10% | 31.48 M | $29.68 |
| Q1 2014 | -200,285 | Reduce 0.66% | 30.24 M | $32.12 |
| Q4 2013 | -271,348 | Reduce 0.88% | 30.44 M | $30.63 |
| Q3 2013 | -25,787 | Reduce 0.08% | 30.71 M | $28.73 |
| Q2 2013 | +30.74 M | Add 0.00% | 30.74 M | $28.01 |
Ken Fisher's Pfizer Investment FAQs
Ken Fisher first purchased Pfizer Inc. (PFE) in Q2 2013, acquiring 30,739,957 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Pfizer Inc. (PFE) for 51 quarters since Q2 2013.
Ken Fisher's largest addition to Pfizer Inc. (PFE) was in Q1 2025, adding 47,440,029 shares worth $1.2 B.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 51,952,106 shares of Pfizer Inc. (PFE), valued at approximately $1.29 B.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.44% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Pfizer Inc. (PFE) was 51,952,106 shares, as reported at the end of Q4 2025.